Diabetic Retinopathy is a complication of diabetes that affects the eyes. It's caused by damage to the blood vessels in the light-sensitive tissue at the back of the eye (retina). The condition can progressively worsen and potentially lead to blindness. Treatment options include: Focal/Grid Laser Photocoagulation, Intravitreal Injections (Anti-VEGF agents or Corticosteroids), and Vitrectomy. These interventions aim to reduce the risk of vision loss and improve overall visual function.
Diabetic Retinopathy is a complication of diabetes that affects the eyes. It's caused by damage to the blood vessels in the light-sensitive tissue at the back of the eye (retina). The condition can progressively worsen and potentially lead to blindness. Treatment options include: Focal/Grid Laser Photocoagulation, Intravitreal Injections (Anti-VEGF agents or Corticosteroids), and Vitrectomy. These interventions aim to reduce the risk of vision loss and improve overall visual function.
Diabetic Retinopathy is treated through various methods including focal laser photocoagulation, intravitreal injections, and vitrectomy. New Zealand's public healthcare system covers some costs, but waiting times can be long.
Private clinics offer faster access for a fee. Average cost for private treatment: NZD 5000-10000.